StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Agape ATP Corporation
NasdaqCM:ATPC
Sector
Industries
Location
Market Cap
USD 70.51 M
Share Price
USD 1.41
Avg Daily Volume
176,161
Change (1 day)
-1.40%
Change (1 year)
Change (YTD)
52.43%
Agape ATP Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -2.34 M
Agape ATP Corporation EBITDA is USD -2.34 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 5.96% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Agape ATP Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -2.21 M, a 47.73% change year over year.
-
Agape ATP Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -1.49 M, a -4.84% change year over year.
-
Agape ATP Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -1.57 M, a 1,204.41% change year over year.
-
Agape ATP Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -120.37 K, a -82.29% change year over year.
Competitors
Eli Lilly and Company
USD 790.65
LLY
+3.73
0.47%
Johnson & Johnson
USD 157.69
JNJ
+1.41
0.90%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
McKesson Corporation
USD 714.54
MCK
-12.69
-1.75%
Elevance Health Inc.
USD 345.86
ELV
-0.50
-0.14%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
CSL Limited
USD 159.67
CSL.AX
+0.42
0.26%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Eli Lilly and Company
USD 790.65
LLY
+3.73
0.47%
Johnson & Johnson
USD 157.69
JNJ
+1.41
0.90%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
McKesson Corporation
USD 714.54
MCK
-12.69
-1.75%
Elevance Health Inc.
USD 345.86
ELV
-0.50
-0.14%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
CSL Limited
USD 159.67
CSL.AX
+0.42
0.26%